AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...

Novo Nordisk resumed its rally on Tuesday, rising to the top of the Stoxx 600 during early deals and adding 5.7% by 11:05 a.m ...

The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...

Bristol Myers Squibb BMY announced that the European Commission has approved the combination of its blockbuster ...

BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining ...

Celltrion secures European approval recommendation for four biosimilars Celltrion advances its global strategy with a ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...

The CHMP recommendation is a critical step towards obtaining marketing authorisation for filgrastim biosimilar Zefylti in the ...

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...